These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16242634)

  • 21. Synthesis, aggregation, neurotoxicity, and secondary structure of various A beta 1-42 mutants of familial Alzheimer's disease at positions 21-23.
    Murakami K; Irie K; Morimoto A; Ohigashi H; Shindo M; Nagao M; Shimizu T; Shirasawa T
    Biochem Biophys Res Commun; 2002 May; 294(1):5-10. PubMed ID: 12054732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T; Kiliaan AJ; Kadish I
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased Abeta secretion by cells expressing familial Alzheimer's disease-linked mutant presenilin 1.
    Shimojo M; Sahara N; Murayama M; Ichinose H; Takashima A
    Neurosci Res; 2007 Mar; 57(3):446-53. PubMed ID: 17210196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
    Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA
    J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of the inhibitory effects of amyloid beta-protein on synaptic plasticity.
    Rowan MJ; Klyubin I; Wang Q; Anwyl R
    Exp Gerontol; 2004; 39(11-12):1661-7. PubMed ID: 15582282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Requirement of aggregation propensity of Alzheimer amyloid peptides for neuronal cell surface binding.
    Bateman DA; McLaurin J; Chakrabartty A
    BMC Neurosci; 2007 May; 8():29. PubMed ID: 17475015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic analysis of response to traumatic brain injury in a mouse model of Alzheimer's disease (APPsw).
    Crawford FC; Wood M; Ferguson S; Mathura VS; Faza B; Wilson S; Fan T; O'Steen B; Ait-Ghezala G; Hayes R; Mullan MJ
    Brain Res; 2007 Dec; 1185():45-58. PubMed ID: 17961517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of amyloid peptides on A-type K+ currents of Drosophila larval cholinergic neurons.
    Kidd JF; Brown LA; Sattelle DB
    J Neurobiol; 2006 Apr; 66(5):476-87. PubMed ID: 16470685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraneuronal amyloid-beta plays a role in mediating the synergistic pathological effects of apoE4 and environmental stimulation.
    Levi O; Dolev I; Belinson H; Michaelson DM
    J Neurochem; 2007 Nov; 103(3):1031-40. PubMed ID: 17666042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zinc-amyloid beta interactions on a millisecond time-scale stabilize non-fibrillar Alzheimer-related species.
    Noy D; Solomonov I; Sinkevich O; Arad T; Kjaer K; Sagi I
    J Am Chem Soc; 2008 Jan; 130(4):1376-83. PubMed ID: 18179213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Garlic extract exhibits antiamyloidogenic activity on amyloid-beta fibrillogenesis: relevance to Alzheimer's disease.
    Gupta VB; Indi SS; Rao KS
    Phytother Res; 2009 Jan; 23(1):111-5. PubMed ID: 18844255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro model of neurotoxicity of Abeta 1-42 and neuroprotection by a pentapeptide: irreversible events during the first hour.
    Datki Z; Papp R; Zádori D; Soós K; Fülöp L; Juhász A; Laskay G; Hetényi C; Mihalik E; Zarándi M; Penke B
    Neurobiol Dis; 2004 Dec; 17(3):507-15. PubMed ID: 15571986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urokinase-type plasminogen activator inhibits amyloid-beta neurotoxicity and fibrillogenesis via plasminogen.
    Tucker HM; Kihiko-Ehmann M; Estus S
    J Neurosci Res; 2002 Oct; 70(2):249-55. PubMed ID: 12271474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dissecting toxicity of tau and beta-amyloid.
    Götz J; Lim YA; Ke YD; Eckert A; Ittner LM
    Neurodegener Dis; 2010; 7(1-3):10-2. PubMed ID: 20160450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metallothionein-III antagonizes the neurotoxic and neurotrophic effects of amyloid beta peptides.
    Irie Y; Keung WM
    Biochem Biophys Res Commun; 2001 Mar; 282(2):416-20. PubMed ID: 11401474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Environment- and mutation-dependent aggregation behavior of Alzheimer amyloid beta-protein.
    Yamamoto N; Hasegawa K; Matsuzaki K; Naiki H; Yanagisawa K
    J Neurochem; 2004 Jul; 90(1):62-9. PubMed ID: 15198667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 'Nature-inspired' drug-protein complexes as inhibitors of Abeta aggregation.
    Bose M; Gestwicki JE; Devasthali V; Crabtree GR; Graef IA
    Biochem Soc Trans; 2005 Aug; 33(Pt 4):543-7. PubMed ID: 16042540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of YFP to study amyloid-beta associated neurite alterations in live brain slices.
    Brendza RP; Simmons K; Bales KR; Paul SM; Goldberg MP; Holtzman DM
    Neurobiol Aging; 2003 Dec; 24(8):1071-7. PubMed ID: 14643378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta-amyloid induces local neurite degeneration in cultured hippocampal neurons: evidence for neuritic apoptosis.
    Ivins KJ; Bui ET; Cotman CW
    Neurobiol Dis; 1998 Nov; 5(5):365-78. PubMed ID: 10069579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of neuronal dystrophy induced by fibrillar amyloid beta: implications for Alzheimer's disease.
    Grace EA; Rabiner CA; Busciglio J
    Neuroscience; 2002; 114(1):265-73. PubMed ID: 12207971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.